Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Shares Outstanding (Weighted Average) (2016 - 2026)

Ani Pharmaceuticals' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $20.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.8% to $20.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.1 million, a 3.8% increase, with the full-year FY2025 number at $20.1 million, up 3.8% from a year prior.
  • Shares Outstanding (Weighted Average) hit $20.1 million in Q4 2025 for Ani Pharmaceuticals, roughly flat from $20.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ANIP hit a ceiling of $20.1 million in Q3 2025 and a floor of $12.0 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $17.1 million across 5 years, with a median of $17.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.86% in 2021 and later soared 35.09% in 2022.
  • Tracing ANIP's Shares Outstanding (Weighted Average) over 5 years: stood at $12.6 million in 2021, then rose by 29.09% to $16.3 million in 2022, then increased by 10.71% to $18.0 million in 2023, then grew by 7.32% to $19.3 million in 2024, then grew by 3.8% to $20.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ANIP at $20.1 million in Q4 2025, $20.1 million in Q3 2025, and $19.7 million in Q2 2025.